ASCETTS R21: Early proof-of-concept tech to speed translational science (no clinical trials)
NIH NCATS is offering ASCETTS R21 awards to support early-stage, high-risk, high-reward technology development that could remove bottlenecks in translating research into new treatments. Projects should be disease-agnostic and focused on prototyping or platform/data-driven technology, with little or no preliminary data. The NOFO excludes clinical trials and does not fund studies that are not pr…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers